Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Cardiovascularsystem%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
/vufind/Search/Results?lookfor=%22Cardiovascularsystem%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
Search /vufind/Search2/Results?lookfor=%22Cardiovascularsystem%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
PubPharm (41)
1
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Pemafibrate to reduce risk of cardiovascular events in patients with diabetes. : Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
41
Aufsätze
41
E-Artikel
41
E-Ressourcen
Zeitschriftentitel
40
WHO International Clinical Trials Registry Plat...
1
Current topics in medicinal chemistry
Thema
40
610
40
Study Type: Interventional
30
Phase: Phase 3
28
Recruitment Status: Not yet recruiting
16
Medical Condition: Reduction of cardiovascular ...
12
Recruitment Status: Authorised-recruitment may ...
6
Medical Condition: Cardiovascular events in pat...
4
Phase: Phase 2
2
Medical Condition: Cardiovascular events in pat...
2
Medical Condition: Cardiovascular events in pat...
2
Medical Condition: Cardiovascular events in pat...
2
Medical Condition: Microvascular myocardial dys...
2
Medical Condition: PCI (percutaneous coronary i...
2
Medical Condition: Reduction of cardiovascular ...
2
Medical Condition: diabetes mellitus type 2, in...
2
Medical Condition: patients affected by type 2 ...
2
Medical Condition: patients with type 2 diabete...
2
Phase: Phase 4
1
Cardiovascular diseases
1
Cardiovascularsystem
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
23
2020-
18
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
41
Englisch
Haven't found what you're looking for?
Wird geladen...